RSS   Newsletter   Contact   Advertise with us
Post Online Media

Endo CEO Rajiv De Silva steps down, replaced by former Par CEO

Paul V CampanelliEndo International plc, a specialty healthcare company, announced that it has named Paul V. Campanelli president and chief executive officer.

Mr. Campanelli currently serves as President of Endo's Generic and OTC drugs business, Par Pharmaceutical.

Article continues below

READ MORE Endocyte appoints Mike Sherman as president and CEO

Mr. Campanelli joined Endo in 2015 following Endo's acquisition of Par Pharmaceutical, where he had served as Chief Executive Officer since 2012. Since joining Endo, he has overseen the Company's U.S. Generic Pharmaceuticals business.

Prior to becoming CEO of Par in 2012, Mr. Campanelli served as Chief Operating Officer of Par Pharmaceutical. Previously, he held roles of increasing responsibility at Par, including President, Par Generics, and Executive Vice President, Business Development & Licensing for branded and generic products.

He has more than 25 years of experience in the generics and branded pharmaceutical industry.

Mr. Campanelli, who will also join Endo's Board of Directors, succeeds Rajiv De Silva, who has stepped down as President, CEO and a member of the Board.




What to read next



 LATEST MOVES FROM Ireland 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy